Press TV 2014.08.25 19:42
Medical workers treat an Ebola patient in Monrovia, Liberia. (File photo)
Japan has expressed readiness to provide a Japanese-developed anti-
influenza drug as a possible treatment for the deadly and rapidly expanding
Ebola virus in West Africa.
Speaking at a news conference in Tokyo on Monday, chief Cabinet Secretary
Yoshihide Suga stated that the drug, developed by Fujifilm subsidiary
Toyama Chemical Co.
DRUG, INFLUENZA, JAPAN, TREATMENT, SUBSIDIARY, TABLET, Toyama Chemical Co., Fujifilm Holdings Corp., Mapp Biopharmaceutical Inc., Japan, USA